Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

764
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
764
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

1.6K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.6K
Olfactory Receptors: Location and Structure01:03

Olfactory Receptors: Location and Structure

9.5K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
9.5K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

361
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
361
Physiology of Smell and Olfactory Pathway01:20

Physiology of Smell and Olfactory Pathway

9.2K
Humans detect odors with the help of specialized cells located in the upper part of the nasal cavity, called olfactory receptor neurons (ORNs). ORNs possess hair-like structures called cilia, which are receptive to sensations from the inhaled air. When an odorant molecule binds to a specific receptor on the cell of the cilia, it leads to a series of events that ultimately cause the ORN to send electrical signals to the olfactory bulb in the brain through the olfactory nerves.
The olfactory...
9.2K
Olfaction01:25

Olfaction

44.8K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
44.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-Frequency Electrocochleography Results in Fewer Drop Alarms During Cochlear Implant Insertion.

The Laryngoscope·2026
Same author

Ossicular Chain Reconstruction Using Glass Ionomer Cement: Cement Alone and Cement with a Titanium Prosthesis Having a Helical Coil.

Otolaryngologic clinics of North America·2025
Same author

Artificial Intelligence for Diagnosis in Otologic Patients: Is It Ready to Be Your Doctor?

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2024
Same author

Amplitude Parameters Are Predictive of Hearing Preservation in a Randomized Controlled Trial of Intracochlear Electrocochleography During Cochlear Implant Surgery.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·2024
Same author

Are Computed Tomography Scans Necessary for the Diagnosis of Peritonsillar Abscess?

Cureus·2023
Same author

Multi-institutional search for patient factors associated with adverse events following tracheotomy.

American journal of otolaryngology·2023

Related Experiment Video

Updated: Aug 29, 2025

Author Spotlight: Advancing Endoscopic Ossiculoplasty – Techniques, Innovations, and Practical Guidance for Clinical Integration
09:07

Author Spotlight: Advancing Endoscopic Ossiculoplasty – Techniques, Innovations, and Practical Guidance for Clinical Integration

Published on: January 26, 2024

2.5K

Endocannabinoid System and the Otolaryngologist.

Brandon Tapasak1, Luke Edelmayer2, Michael D Seidman3

  • 1University of Central Florida College of Medicine, 6850 Lake Nona Boulevard, Orlando, FL 32827, USA.

Otolaryngologic Clinics of North America
|September 10, 2022
PubMed
Summary
This summary is machine-generated.

Medical cannabinoids show promise for treating ear, nose, and throat (ENT) conditions by interacting with the endocannabinoid system. Further research is needed to explore benefits and potential drawbacks for otolaryngologic pathologies.

Keywords:
Cannabinoid drugsCannabisDizzinessEndocannabinoid systemHead and neck cancerObstructive sleep apneaTinnitusVertigo

More Related Videos

A Method of Nodose Ganglia Injection in Sprague-Dawley Rat
09:28

A Method of Nodose Ganglia Injection in Sprague-Dawley Rat

Published on: November 25, 2014

19.0K
Harvest of Vestibular End-Organs under Physiologic Conditions during Labyrinthectomy
03:08

Harvest of Vestibular End-Organs under Physiologic Conditions during Labyrinthectomy

Published on: November 29, 2024

483

Related Experiment Videos

Last Updated: Aug 29, 2025

Author Spotlight: Advancing Endoscopic Ossiculoplasty – Techniques, Innovations, and Practical Guidance for Clinical Integration
09:07

Author Spotlight: Advancing Endoscopic Ossiculoplasty – Techniques, Innovations, and Practical Guidance for Clinical Integration

Published on: January 26, 2024

2.5K
A Method of Nodose Ganglia Injection in Sprague-Dawley Rat
09:28

A Method of Nodose Ganglia Injection in Sprague-Dawley Rat

Published on: November 25, 2014

19.0K
Harvest of Vestibular End-Organs under Physiologic Conditions during Labyrinthectomy
03:08

Harvest of Vestibular End-Organs under Physiologic Conditions during Labyrinthectomy

Published on: November 29, 2024

483

Area of Science:

  • Neuroscience
  • Pharmacology
  • Otolaryngology

Background:

  • The endocannabinoid system (ECS) is a complex cell-signaling system present in the central and peripheral nervous systems, endocrine, and gastrointestinal systems.
  • Medical cannabinoids are increasingly recognized for their therapeutic potential across various medical conditions.
  • Otolaryngologic (ear, nose, and throat) pathologies represent an area with ongoing research into cannabinoid efficacy.

Purpose of the Study:

  • To identify otolaryngologic conditions where medical cannabinoids may offer therapeutic benefits.
  • To discuss the potential advantages and disadvantages associated with cannabinoid use in otolaryngology.
  • To propose future research directions for cannabinoid applications in this specialty.

Main Methods:

  • Literature review of existing studies on the endocannabinoid system and medical cannabinoids.
  • Analysis of research pertaining to cannabinoid effects on common otolaryngologic diseases.
  • Synthesis of information regarding potential benefits, drawbacks, and future research needs.

Main Results:

  • The endocannabinoid system is widely distributed, suggesting broad physiological influence.
  • Cannabinoids demonstrate potential for treating specific otolaryngologic conditions, though evidence is still emerging.
  • Potential drawbacks and risks associated with cannabinoid use require careful consideration.

Conclusions:

  • Medical cannabinoids represent a potential therapeutic avenue for certain otolaryngologic pathologies.
  • Further rigorous research is essential to establish efficacy, safety, and optimal usage protocols.
  • Understanding the endocannabinoid system's role is key to advancing cannabinoid-based treatments in otolaryngology.